Texanol: a paint additive; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 6490 |
CHEMBL ID | 3184970 |
SCHEMBL ID | 56321 |
MeSH ID | M0522465 |
Synonym |
---|
LS-14159 |
2,2,4-trimethyl-1,3-pentanediol monoisobutyrate |
texanol |
NCGC00164419-01 |
25265-77-4 |
(3-hydroxy-2,2,4-trimethylpentyl) 2-methylpropanoate |
2,2,4-trimethyl-1,3-pentanediol 1-isobutyrate |
3-hydroxy-2,2,4-trimethylpentyl isobutyrate |
I0405 |
isobutyric acid 3-hydroxy-2,2,4-trimethylpentyl ester |
NCGC00248541-01 |
propanoic acid, 2-methyl-, 3-hydroxy-2,2,4-trimethylpentyl ester |
77-68-9 |
9lji14453c , |
unii-9lji14453c |
einecs 201-049-2 |
1,3-pentanediol, 2,2,4-trimethyl-, 1-isobutyrate |
isobutyraldehyde trimer |
tox21_200148 |
cas-25265-77-4 |
dsstox_rid_78592 |
NCGC00257702-01 |
dsstox_gsid_27857 |
dsstox_cid_7857 |
2,2,4-trimethyl-1,3-pentanediolmono(2-methylpropanoate) |
AKOS015900105 |
isobutyric acid, 3-hydroxy-2,2,4-trimethylpentyl ester |
2,2,4-trimethyl-1,3-pentanediol 1-isobutyrate, (+/-)- |
(+/-)-2,2,4-trimethyl-1,3-pentanediol 1-isobutyrate |
SCHEMBL56321 |
3-hydroxy-2,2,4-trimethylpentyl 2-methylpropionate |
component of texanol |
3-hydroxy-2,2,4-trimethylpentyl 2-methylpropanoate |
CHEMBL3184970 |
J-506772 |
DTXSID10872295 |
mfcd00148967 |
3-hydroxy-2,2,4-trimethylpentyl isobutyrate (contains ca. 40% 2,2,4-trimethyl-1,3-pentanediol 3-monoisobutyrate) |
FT-0699920 |
Q27272708 |
texanolesteralcohol |
2-methyl-propanoic acid 3-hydroxy-2,2,4-trimethylpentyl ester |
3-hydroxy-2,2,4-trimethylpentylisobutyrate |
CS-W014835 |
1185060-32-5 |
isobutyric acid 2,2,4-trimethylpentane-1,3-diol ester |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 13.7272 | 0.0003 | 23.4451 | 159.6830 | AID743065 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (55.30) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (14.29%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |